Acute Respiratory Distress Syndrome Market Size, Share, Growth, Opportunities And Business Challenges 2030: SPER Market Research

Q: How can I get the sample report on the Acute Respiratory Distress Syndrome Market?

You can get the sample pages by clicking the link - Click Here

Published: Oct 2022	Report ID: HLCA2212	Pages: 1 - 206	Formats^*:
Category : Healthcare

Acute Respiratory Distress Syndrome Market Introduction and Overview

According to SPER Market Research, the Global Acute Respiratory Distress Syndrome Market is estimated to reach 5.42 Billion by 2032 with a CAGR of 5.94%.

The report includes an in-depth analysis of the Global Acute Respiratory Distress Syndrome Market, including market size and trends, product mix, Applications, and supplier analysis. A potentially lethal lung damage that results in fluid seeping into the lungs is called acute respiratory distress syndrome (ARDS). Most people who have ARDS are already in the hospital getting better following an injury or receiving treatment. Alveoli, the lungs' tiny, elastic air sacs, are where fluids usually build up and cause the condition. This fluid buildup results in less oxygen reaching the bloodstream. The consequence is that the organs are not getting enough oxygen to function properly. People with various conditions will develop acute respiratory distress syndrome (ARDS) a few hours to many days after the original injury or infection.

In 2021- Announcing the launch of the SonarMed airway monitoring system was Medtronic. The endotracheal tube occlusion is detected by means of acoustic technology in this system. This has led to a growth in the company's product portfolio.

In 2020- According to F. Hoffman-La Roche Ltd., the SARS-CoV-2 rapid antibody test was available. The investigation was initiated in collaboration with SD Biosensor, Inc. This has led to a growth in the company's product portfolio.

Acute Respiratory Distress Syndrome Market

Market Opportunities and Challenges

Opportunities: Diagnoses are becoming more and more necessary, which is driving up the market. According to market predictions, the diagnosis industry will dominate because many patients need many diagnoses to complete their therapy in a timely manner. The market has a ton of opportunities as a result. To educate the public on the variety of diagnosis and treatments that are available, several governments are launching awareness programs. Reputable manufacturers have released several products with enhanced functionality. One example is the SonarMed airway monitoring device, which was released according to Medtronic. This gadget monitors for endotracheal tube occlusion using acoustic technology. This quickens the growth of the market.

Challenges: Throughout the projected period, a shortage of competent professionals who are unaware of the available treatment choices for respiratory distress syndrome may hinder the growth of the global market for respiratory distress syndrome treatments. Prescription costs are increasing concurrently with an increase in the incidence of diseases. The market's growth is being hindered by the rising costs of therapy. ICU nurses encounter numerous obstacles and strict regulations for clearance, which pose a major market challenge for the worldwide acute respiratory distress syndrome (ARDS) market. ARDS treatment complications and high equipment and therapy costs, on the other hand, are hindering the growth of the acute respiratory distress syndrome (ARDS) market globally.

Get more information on this report: Download Free Sample PDF

Market Competitive Landscape

The competitive landscape of the acute respiratory distress syndrome (ARDS) market includes information broken down by competitor. In-depth information is provided about the company's background, finances, revenue, market potential, R&D spending, new market initiatives, global reach, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product breadth and width, and application dominance. Key players are Armstrong Medical, Besmed Health Business Corp, Bayer AG, DrÃ¤gerwerk AG & Co KGaA, EUROSETS, Fisher & Paykel Healthcare Limited, F. Hoffmann-La Roche Ltd, Getinge AB, LivaNova PLC, and Pfizer Inc are a few of the top companies in the sector.

Scope of the report

Report Metric	Details
Market size available for years	2019-2032
Base year considered	2021
Forecast period	2022-2032
Segments covered	By Type, By Cause, By Route of Administration, By End-User Industry, By Distribution Channel
Geographies covered	North America, Asia-Pacific, Latin America, Middle East &Africa and Europe
Companies Covered	Armstrong Medical, Besmed Health Business Corp, Bayer AG, DrÃ¤gerwerk AG & Co KGaA, EUROSETS, Fisher & Paykel Healthcare Limited, F. Hoffmann-La Roche Ltd, Getinge AB, LivaNova PLC, Pfizer Inc.

COVID-19 Impact on Global Acute Respiratory Distress Syndrome Market

The COVID-19 pandemic had an impact on the world economy. The disease was extremely common and infectious throughout the pandemic and even in the post-pandemic era, which led to the progressive development of respiratory disorders like pneumonia and acute respiratory distress syndrome. Consequently, the global market for respiratory distress syndrome medications had a notable surge following the COVID-19 pandemic. The global healthcare and pharmaceutical industries have been greatly impacted by the COVID-19 pandemic. Regarding the ARDS market, this epidemic has been extremely beneficial. Furthermore, contributing to the market's expansion has been the public's growing awareness of ARDS because of this outbreak.

Key Target Audience

Hospitals and Critical Care Units
Pulmonologists and Intensivists
Respiratory Therapists
Nurses
Medical Device Manufacturers
Pharmaceutical Companies
Government Agencies
Research Institutions and Academia
Patient Advocacy Groups
Investors and Venture Capitalists

Our in-depth analysis of the Acute Respiratory Distress Syndrome Market includes the following segments:

By Type:	Diagnosis Treatment
By Cause:	Coronavirus Disease 2019 (COVID-19) Sepsis Inhalation of Harmful Substances Severe Pneumonia Others
By Route of Administration:	Oral Parenteral Intramuscular Intravenous Others
By End-user Industry:	Hospitals Specialty Clinics Home Healthcare Others
By Distribution Channel:	Direct Tender Hospital Pharmacy Retail Pharmacy Online Pharmacy Others

Key Topics Covered in the Report

Global Acute Respiratory Distress Syndrome Market Size (FYâ€™2022-FYâ€™2032)
Overview of Global Acute Respiratory Distress Syndrome Market
Segmentation of Global Acute Respiratory Distress Syndrome Market By Type (Diagnosis, Treatment)
Segmentation of Global Acute Respiratory Distress Syndrome Market By Cause (Coronavirus Disease 2019 (COVID-19), Sepsis, Inhalation of Harmful Substances, Severe Pneumonia, Others)
Segmentation of Global Acute Respiratory Distress Syndrome Market By Route of Administration (Oral, Parenteral, Intramuscular, Intravenous, Others)
Segmentation of Global Acute Respiratory Distress Syndrome Market By End-user Industry (Hospitals, Specialty Clinics, Home Healthcare, Others)
Segmentation of Global Acute Respiratory Distress Syndrome Market By Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy,
Others)
Statistical Snap of Global Acute Respiratory Distress Syndrome Market
Expansion Analysis of Global Acute Respiratory Distress Syndrome Market
Problems and Obstacles in Global Acute Respiratory Distress Syndrome Market
Competitive Landscape in the Global Acute Respiratory Distress Syndrome Market
Impact of COVID-19 and Demonetization on Global Acute Respiratory Distress Syndrome Market
Details on Current Investment in Global Acute Respiratory Distress Syndrome Market
Competitive Analysis of Global Acute Respiratory Distress Syndrome Market
Prominent Players in the Global Acute Respiratory Distress Syndrome Market
SWOT Analysis of Global Acute Respiratory Distress Syndrome Market
Global Acute Respiratory Distress Syndrome Market Future Outlook and Projections (FYâ€™2022-FYâ€™2032)
Recommendations from Analyst

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source

2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERâ€™s internal database
2.1.4. Premium insight from KOLâ€™s

2.2. Market size estimation

2.2.1. Top-down and Bottom-up approach

2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis

4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges

4.2. COVID-19 Impacts of the Global Acute Respiratory Distress Syndrome Market.

5. Market variable and outlook

5.1. SWOT Analysis

5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats

5.2. PESTEL Analysis

5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape

5.3. PORTERâ€™s Five Forces

5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry

5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Acute Respiratory Distress Syndrome Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Acute Respiratory Distress Syndrome Market

7. Global Acute Respiratory Distress Syndrome Market, By Type (USD Million) 2019-2032

7.1. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Type, 2019-2025
7.2. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Type, 2026-2032
7.3. Diagnosis
7.4. Treatment

8. Global Acute Respiratory Distress Syndrome Market, By Cause (USD Million) 2019-2032

8.1. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Cause, 2019-2025
8.2. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Cause, 2026-2032
8.3. Coronavirus Disease 2019 (COVID-19)
8.4. Sepsis
8.5. Inhalation of Harmful Substances
8.6. Severe Pneumonia
8.7. Others

9. Global Acute Respiratory Distress Syndrome Market, By Route of Administration (USD Million) 2019-2032

9.1. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Route of Administration, 2019-2025
9.2. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Route of administration, 2026-2032
9.3. Oral
9.4. Parenteral
9.5. Intramuscular
9.6. Intravenous
9.7. Others

10. Global Acute Respiratory Distress Syndrome Market, By End-user Industry (USD Million) 2019-2032

10.1. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By End-user Industry, 2019-2025
10.2. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By End-user Industry, 2026-2032
10.3. Hospitals
10.4. Specialty Clinics
10.5. Home Healthcare
10.6. Others

11. Global Acute Respiratory Distress Syndrome Market, By Distribution Channel (USD Million) 2019-2032

11.1. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Distribution Channel, 2019-2025
11.2. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Distribution Channel, 2026-2032
11.3. Direct Tender
11.4. Hospital Pharmacy
11.5. Retail Pharmacy
11.6. Online Pharmacy
11.7. Others

12. Global Acute Respiratory Distress Syndrome Market Forecast, 2019-2032 (USD Million)

12.1. Global Acute Respiratory Distress Syndrome Market Size and Market Share

13. Global Acute Respiratory Distress Syndrome Market, By Region, 2019-2032 (USD Million)

13.1. Global Acute Respiratory Distress Syndrome Market Size and Market Share By Region (2019-2025)
13.2. Global Acute Respiratory Distress Syndrome Market Size and Market Share By Region (2026-2032)
13.3. Asia-Pacific

13.3.1. Australia
13.3.2. China
13.3.3. India
13.3.4. Japan
13.3.5. South Korea
13.3.6. Rest of Asia-Pacific

13.4. Europe

13.4.1. France
13.4.2. Germany
13.4.3. Italy
13.4.4. Spain
13.4.5. United Kingdom
13.4.6. Rest of Europe

13.5. Middle East and Africa

13.5.1. Kingdom of Saudi Arabia
13.5.2. United Arab Emirates
13.5.3. Qatar
13.5.4. South Africa
13.5.5. Egypt
13.5.6. Morocco
13.5.7. Nigeria
13.5.8. Rest of Middle-East and Africa

13.6. North America

13.6.1. Canada
13.6.2. Mexico
13.6.3. United States

13.7. Latin America

13.7.1. Argentina
13.7.2. Brazil
13.7.3. Rest of Latin America

14. Company Profile

14.1. Armstrong Medical

14.1.1. Company details
14.1.2. Financial outlook
14.1.3. Product summary
14.1.4. Recent developments

14.2. Besmed Health Business Corp.

14.2.1. Company details
14.2.2. Financial outlook
14.2.3. Product summary
14.2.4. Recent developments

14.3. Bayer AG

14.3.1. Company details
14.3.2. Financial outlook
14.3.3. Product summary
14.3.4. Recent developments

14.4. DrÃ¤gerwerk AG & Co. KGaA.

14.4.1. Company details
14.4.2. Financial outlook
14.4.3. Product summary
14.4.4. Recent developments

14.5. EUROSETS

14.5.1. Company details
14.5.2. Financial outlook
14.5.3. Product summary
14.5.4. Recent developments

14.6. Fisher & Paykel Healthcare Limited

14.6.1. Company details
14.6.2. Financial outlook
14.6.3. Product summary
14.6.4. Recent developments

14.7. F. Hoffmann-La Roche Ltd

14.7.1. Company details
14.7.2. Financial outlook
14.7.3. Product summary
14.7.4. Recent developments

14.8. Getinge AB

14.8.1. Company details
14.8.2. Financial outlook
14.8.3. Product summary
14.8.4. Recent developments

14.9. LivaNova PLC

14.9.1. Company details
14.9.2. Financial outlook
14.9.3. Product summary
14.9.4. Recent developments

14.10. Pfizer Inc.

14.10.1. Company details
14.10.2. Financial outlook
14.10.3. Product summary
14.10.4. Recent developments

14.11. Others

15. Conclusion

16. List of Abbreviation

17. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Frequently Asked Questions About This Report

How big is the Acute Respiratory Distress Syndrome Market?

The Acute Respiratory Distress Syndrome Market is projected to reach USD 5.42 billion by 2032, growing at a CAGR of 5.94% during the forecast period.

What is the growth rate of the Acute Respiratory Distress Syndrome Market?

The Acute Respiratory Distress Syndrome Market grew in market size from 2021. The Market is expected to reach USD 5.42 billion by 2032, at a CAGR of 5.94% during the forecast period.

What is the anticipated CAGR of the Acute Respiratory Distress Syndrome Market during the forecast period?

The Acute Respiratory Distress Syndrome Market CAGR of 5.94% during the forecast period.

How can I get the sample report on the Acute Respiratory Distress Syndrome Market?

You can get the sample pages by clicking the link - Click Here

What is the market size of the Acute Respiratory Distress Syndrome Market in 2032?

The Acute Respiratory Distress Syndrome Market size is USD 5.42 billion from 2022 to 2032.

Which segment is expected to lead the Acute Respiratory Distress Syndrome Market during the forecast period?

The Acute Respiratory Distress Syndrome Market segment is Covered By Type, By Cause, By Route of Administration, By End-User Industry, By Distribution Channel.

Which region is expected to have the highest market share in the Acute Respiratory Distress Syndrome Market?

The North America region is anticipated to have the highest market share in the Acute Respiratory Distress Syndrome Market.

Who are the key players in Acute Respiratory Distress Syndrome Market?

The key players in the market include Companies Covered Armstrong Medical, Besmed Health Business Corp, Bayer AG, Drägerwerk AG & Co KGaA, EUROSETS, Fisher & Paykel Healthcare Limited, F. Hoffmann-La Roche Ltd, Getinge AB, LivaNova PLC, Pfizer Inc.

What is the conclusion of the Acute Respiratory Distress Syndrome Market?

Most people who have ARDS are already in the hospital getting better following an injury or receiving treatment.